Item 2.02. Results of Operations and Financial Condition

On April 6, 2020, Natus Medical Incorporated (the "Company") issued a press release announcing preliminary first quarter revenue and withdrawing full year 2020 guidance. The information in this Item 2.02 and the exhibit attached hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

Item 7.01. Regulation FD Disclosure.

The April 6, 2020 press release furnished as Exhibit 99.1 hereto also provides an update on the Company's current business operations as a result of the uncertainty created by COVID-19 pandemic and withdraws guidance for the full year 2020 in light of the COVID-19 pandemic.

The information under this Item 7.01 and in Exhibit 99.1, is being furnished and is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934 and is not to be incorporated by reference into any filing of the registrant under the Securities Act of 1933 or the Securities Exchange Act of 1934, whether made before or after the date hereof, regardless of any general incorporation language in any such filing, except as shall be expressly set forth by specific reference in such a filing.




Item 9.01.     Financial Statements and Exhibits


(d) Exhibits.


 Exhibit No.            Description
  99.1                    Press release dated April 6, 2020.
                        The cover page from this Current Report on Form 8-K, formatted in Inline
104                     XBRL (included as Exhibit 101).

© Edgar Online, source Glimpses